TY - JOUR
T1 - Development and reliability of the new endoscopic virtual chromoendoscopy score
T2 - the PICaSSO (Paddington International Virtual ChromoendoScopy ScOre) in ulcerative colitis
AU - Iacucci, Marietta
AU - Daperno, Marco
AU - Lazarev, Mark
AU - Arsenascu, Razvan
AU - Tontini, Gian Eugenio
AU - Akinola, Oluseyi
AU - Gui, Xianyong Sean
AU - Villanacci, Vincenzo
AU - Goetz, Martin
AU - Lowerison, Mark
AU - Lethebe, Brendan Cord
AU - Vecchi, Maurizio
AU - Neumann, Helmut
AU - Ghosh, Subrata
AU - Bisschops, Raf
AU - Kiesslich, Ralf
N1 - Publisher Copyright:
© 2017 American Society for Gastrointestinal Endoscopy
PY - 2017/12
Y1 - 2017/12
N2 - Background and Aims Endoscopic inflammation and healing are important therapeutic endpoints in ulcerative colitis (UC). We developed and validated a new electronic virtual chromoendoscopy (EVC) score that could reflect the full spectrum of mucosal and vascular changes including mucosal healing in UC. Methods Eight participants reviewed a 60-minute training module outlining 3 different i-SCAN modes demonstrating the entire spectrum of inflammatory mucosal and vascular changes in UC. Performance characteristics in endoscopic scoring and predicting the histologic inflammation with EVC (i-SCAN) by using 20 video clips before (pre-test) and after (post-test) were evaluated. Exploratory univariate factor analysis was performed on Paddington International Virtual Chromoendoscopy Score (PICaSSO) covariates for mucosal and vascular score separately. Subsequently, a proportional odds logistic regression model for the prediction of histologic scores was analyzed. Results The interobserver agreement for Mayo endoscopic score in the pre-test (κ =.85; 95% CI,.78-.90) and the post-test (κ =.85; 95% CI,.77-.90) evaluation were very good. This was also true for the Ulcerative Colitis Endoscopic Index of Severity in the pre-test and post-test score interobserver agreement (κ =.86; 95% CI,.77-.92; and κ =.84; 95% CI,.75-.91, respectively). The interobserver agreement of the PICaSSO endoscopic score was very good in the pre-test and post-test evaluations (κ =.92; 95% CI,.87-.96; and κ =.89; 95% CI,.84-.94, respectively). The accuracy of the overall PICaSSO in assessing histologic abnormalities and inflammation by Harpaz score was 57% (95% CI, 48%-65%), by Robarts Histological Index 72% (95% CI, 64%-79%), and by the extent, chronicity, activity, plus system (full spectrum of histologic changes) 83% (95% CI, 76%-88%). Conclusions The EVC score “PICaSSO” showed very good interobserver agreement. The new EVC score may be used to define the endoscopic findings of mucosal and vascular healing in UC and reflected the full spectrum of histologic changes.
AB - Background and Aims Endoscopic inflammation and healing are important therapeutic endpoints in ulcerative colitis (UC). We developed and validated a new electronic virtual chromoendoscopy (EVC) score that could reflect the full spectrum of mucosal and vascular changes including mucosal healing in UC. Methods Eight participants reviewed a 60-minute training module outlining 3 different i-SCAN modes demonstrating the entire spectrum of inflammatory mucosal and vascular changes in UC. Performance characteristics in endoscopic scoring and predicting the histologic inflammation with EVC (i-SCAN) by using 20 video clips before (pre-test) and after (post-test) were evaluated. Exploratory univariate factor analysis was performed on Paddington International Virtual Chromoendoscopy Score (PICaSSO) covariates for mucosal and vascular score separately. Subsequently, a proportional odds logistic regression model for the prediction of histologic scores was analyzed. Results The interobserver agreement for Mayo endoscopic score in the pre-test (κ =.85; 95% CI,.78-.90) and the post-test (κ =.85; 95% CI,.77-.90) evaluation were very good. This was also true for the Ulcerative Colitis Endoscopic Index of Severity in the pre-test and post-test score interobserver agreement (κ =.86; 95% CI,.77-.92; and κ =.84; 95% CI,.75-.91, respectively). The interobserver agreement of the PICaSSO endoscopic score was very good in the pre-test and post-test evaluations (κ =.92; 95% CI,.87-.96; and κ =.89; 95% CI,.84-.94, respectively). The accuracy of the overall PICaSSO in assessing histologic abnormalities and inflammation by Harpaz score was 57% (95% CI, 48%-65%), by Robarts Histological Index 72% (95% CI, 64%-79%), and by the extent, chronicity, activity, plus system (full spectrum of histologic changes) 83% (95% CI, 76%-88%). Conclusions The EVC score “PICaSSO” showed very good interobserver agreement. The new EVC score may be used to define the endoscopic findings of mucosal and vascular healing in UC and reflected the full spectrum of histologic changes.
UR - http://www.scopus.com/inward/record.url?scp=85018383016&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85018383016&partnerID=8YFLogxK
U2 - 10.1016/j.gie.2017.03.012
DO - 10.1016/j.gie.2017.03.012
M3 - Article
C2 - 28322774
AN - SCOPUS:85018383016
SN - 0016-5107
VL - 86
SP - 1118-1127.e5
JO - Gastrointestinal endoscopy
JF - Gastrointestinal endoscopy
IS - 6
ER -